From the Unit on Perinatal and Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; and the Division of Maternal Fetal Medicine, Columbia University Medical Center, New York, New York.
Obstet Gynecol. 2010 Feb;115(2 Pt 1):350-356. doi: 10.1097/AOG.0b013e3181cb59da.
To evaluate whether treatment with neuroprotective peptides to young adult mice prenatally exposed to alcohol reverses alcohol-induced learning deficits in a mouse model of fetal alcohol syndrome, whether the mechanism involves the N-methyl-d-aspartate (NMDA) and gamma-aminobutyric acid type A (GABAA) receptors, and whether it is related to glial cells.
C57Bl6/J mice were treated with alcohol (0.03 ml/g) or placebo on gestational day 8. On day 40, male mice exposed to alcohol in utero were treated daily for 10 days with D-NAPVSIPQ and D-SALLRSIPA (n=20) or placebo (n=13); and control offspring were treated with placebo (n=46), with the treatment blinded. Learning evaluation began after 3 days using the Morris watermaze and the T-maze. The hippocampus, cortex, and cerebellum were isolated. Expression of NR2A, NR2B, GABAAbeta3, GABAAalpha5, vasoactive intestinal peptide (VIP), activity-dependent neuroprotective protein, and glial fibrillary acidic protein was measured using calibrator-normalized relative real-time polymerase chain reaction. Statistical analysis included analysis of variance and Fisher's protected least significant difference.
Treatment with D-NAPVSIPQ and D-SALLRSIPA reversed the alcohol-induced learning deficit in both learning tests as well as the NR2A and NR2B down-regulation in the hippocampus and the up-regulation of NR2A in the cortex and NR2B in the cortex and cerebellum (all P<.05). No significant differences were found in GABAA expression. Moreover, the peptides changed activity-dependent neuroprotective protein expression in the cortex (P=.016) but not the down-regulation of VIP (P=.883), probably because the peptides are downstream from VIP.
Alcohol-induced learning deficit was reversed and expression of NR2A and NR2B was restored in the hippocampus and cortex of young adult mice treated with D-NAPVSIPQ and D-SALLRSIPA. Given the role of NMDA receptors in learning, this may explain in part the mechanism of prevention of alcohol-induced learning deficits by D-NAPVSIPQ and D-SALLRSIPA.
评估对产前酒精暴露的成年幼鼠给予神经保护肽治疗是否能逆转胎儿酒精综合征小鼠模型中的酒精诱导的学习缺陷,该机制是否涉及 N-甲基-D-天冬氨酸(NMDA)和γ-氨基丁酸 A 型(GABAA)受体,以及它是否与神经胶质细胞有关。
C57Bl6/J 小鼠在妊娠第 8 天接受酒精(0.03ml/g)或安慰剂处理。在第 40 天,宫内暴露于酒精的雄性幼鼠每日接受 D-NAPVSIPQ 和 D-SALLRSIPA(n=20)或安慰剂(n=13)治疗 10 天;而对照组幼鼠接受安慰剂(n=46)治疗,治疗过程中设盲。使用 Morris 水迷宫和 T 迷宫在第 3 天后开始进行学习评估。分离出海马体、皮质和小脑。使用校准标准化相对实时聚合酶链反应测量 NR2A、NR2B、GABAAβ3、GABAAα5、血管活性肠肽(VIP)、活性依赖性神经保护蛋白和神经胶质纤维酸性蛋白的表达。统计分析包括方差分析和 Fisher 的保护最小显著差异。
D-NAPVSIPQ 和 D-SALLRSIPA 治疗逆转了两种学习测试中的酒精诱导的学习缺陷,以及海马体中 NR2A 和 NR2B 的下调和皮质中 NR2A 和小脑中 NR2B 的上调(均 P<.05)。GABAA 表达无显著差异。此外,这些肽改变了皮质中的活性依赖性神经保护蛋白表达(P=.016),但没有改变 VIP 的下调(P=.883),可能是因为这些肽位于 VIP 下游。
D-NAPVSIPQ 和 D-SALLRSIPA 治疗可逆转年轻成年幼鼠的学习缺陷,并恢复海马体和皮质中 NR2A 和 NR2B 的表达。鉴于 NMDA 受体在学习中的作用,这可能部分解释了 D-NAPVSIPQ 和 D-SALLRSIPA 预防酒精诱导的学习缺陷的机制。